CFO
LH icon

Callan Family Office’s Labcorp LH Stock Holding History

Callan Family Office’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$357K Sell
1,338
-65
-5% -$17.6K 0.01% 872
2025
Q4 		$352K Buy
1,403
+263
+23% +$69.8K 0.01% 879
2025
Q3 		$327K Sell
1,140
-281
-20% -$75.3K 0.01% 677
2025
Q2 		$373K Buy
+1,421
New +$346K 0.01% 697

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Callan Family Office's LH Position: Q1 2026 in Review

Callan Family Office reduced its Labcorp (LH) stake by 4.6% in Q1 2026, selling an estimated $17.6K and leaving 1,338 shares worth $357K. The position accounts for 0.01% of the portfolio, ranked #872.

Callan Family Office first reported a position in LH in Q2 2025 and has held it in 4 quarters since. The position peaked at $373K in Q2 2025. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Callan Family Office held 1,338 shares of Labcorp worth $357K as of Q1 2026.
  • Callan Family Office sold 65 Labcorp shares in Q1 2026, an estimated $17.6K.
  • Labcorp made up 0.01% of Callan Family Office's portfolio in Q1 2026, its #872 holding.
  • Callan Family Office first reported a position in Labcorp in Q2 2025 and has held it in 4 quarters since.
  • Callan Family Office's Labcorp position peaked at $373K in Q2 2025.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.